Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
P-SCIP
7 other identifiers
interventional
212
1 country
5
Brief Summary
The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant (HSCT). The investigators will evaluate the efficacy of P-SCIP in reducing short- and long-term distress and parenting stress among 300 parents of children undergoing HSCT. P-SCIP will be delivered during the child's inpatient HSCT hospitalization and is specifically designed to improve parent social (e.g., sharing concerns) and cognitive (e.g., acceptance) processing of the transplant experience. The intervention includes five in-person sessions that are accompanied by an interactive CD-ROM. The CD-ROM complements the materials in the in-person sessions and provides parents with the opportunity to enhance and deepen their cognitive and social processing of the HSCT experience. The intervention will be tested against best-practices psychosocial care (BPC) available in four enriched pediatric HSCT settings across the United States. P-SCIP will be provided to both Spanish- and English-speaking parents. Participants will complete measures of psychological distress, well-being, and social and cognitive processing at the time of HSCT, two, six and twelve months after HSCT. Research questions will address the effects of P-SCIP versus BPC on parent psychological adaptation and social and cognitive processing, as well as evaluate parent personal resources as well as child medical course variables that contribute to intervention response. The investigators will also examine barriers to participation in the intervention by comparing barriers to participation among parents who refuse participation in the trial and parents who accept.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2010
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2009
CompletedFirst Posted
Study publicly available on registry
July 15, 2009
CompletedStudy Start
First participant enrolled
May 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedMarch 10, 2016
March 1, 2016
4.7 years
July 14, 2009
March 9, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Beck Depression Inventory
7 years
Beck Anxiety Inventory
7 years
Mental Health Inventory
7 years
Impact of Events Scale-Revised
7 years
Axis I Structured Clinical Interview for DSM-IV (SCID)
7 years
Secondary Outcomes (2)
Fear Structure
7 years
Brief COPE
7 years
Study Arms (2)
P-SCIP
EXPERIMENTALArm I (Parent Social-Cognitive Intervention Program \[P-SCIP\]): Participants undergo five 60-minute behavioral intervention sessions once or twice weekly for 3 weeks to learn how to engage in effective social and cognitive processing to deal with fears and worries about the transplant and transplant-related concerns. Participants receive a laptop computer and a CD-ROM after the first session.
BPC
EXPERIMENTALArm II (Best-recommended Psychosocial Care \[BPC\]): Participants undergo usual care and receive a "Discovery to Recovery" DVD and pamphlet developed by the National Marrow Donor Program (NMDP) describing psychological issues associated with hematopoietic stem cell transplantation (HSCT), the booklet "Top Tips for Parent Caregivers During the BMT Process" published by National Marrow Donor Program-Link describing caregiver issues during HSCT and advice on how to handle them, 2 walkie-talkies, a laptop to view the DVD, and 5 hours of respite care from a child-life specialist once or twice weekly for 3 weeks.
Interventions
Participants undergo five 60-minute behavioral intervention sessions once or twice weekly for 3 weeks to learn how to engage in effective social and cognitive processing to deal with fears and worries about the transplant and transplant-related concerns.
Participants receive a laptop computer and a CD-ROM after the first session of behavioral intervention.
Participants receive a "Discovery to Recovery" DVD and pamphlet developed by the National Marrow Donor Program (NMDP) describing psychological issues associated with hematopoietic stem cell transplantation (HSCT), the booklet "Top Tips for Parent Caregivers During the BMT Process" published by National Marrow Donor Program-Link describing caregiver issues during HSCT and advice on how to handle them, 2 walkie-talkies, a laptop to view the DVD.
Participants receive 5 hours of respite care from a child-life specialist once or twice weekly for 3 weeks.
Eligibility Criteria
You may qualify if:
- biological or foster parent of children under 19 years of age who are scheduled for HSCT within the next month
- participant is the primary caregiver
- participant must have phone service
- caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)
You may not qualify if:
- pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rutgers, The State University of New Jerseylead
- National Cancer Institute (NCI)collaborator
- Children's Hospital Los Angelescollaborator
- Columbia Universitycollaborator
- Emory Universitycollaborator
- Memorial Sloan Kettering Cancer Centercollaborator
- University of Medicine and Dentistry of New Jerseycollaborator
- Icahn School of Medicine at Mount Sinaicollaborator
- Weill Medical College of Cornell Universitycollaborator
- National Marrow Donor Programcollaborator
Study Sites (5)
Childrens Hospital Los Angeles
Los Angeles, California, 90027, United States
Emory University/Childrens Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 080903, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, 10021, United States
Columbia University
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon L Manne, Ph.D.
Rutgers Cancer Institute of New Jersey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2009
First Posted
July 15, 2009
Study Start
May 1, 2010
Primary Completion
January 1, 2015
Study Completion
May 1, 2015
Last Updated
March 10, 2016
Record last verified: 2016-03